Point Guard Biosciences, LLC (PGBio) announced today, it is launching its second annual PGBio Innovation in Ophthalmology Award. This award is created by PGBio to assist entrepreneurs in the area of ophthalmology with financial help as well as assistance with strategic planning.
“This award is focused on advancing innovative technologies currently in preclinical or early clinical stages of development that have clinical application in critical areas of ophthalmology” says Barry Butler, CEO of Point Guard Biosciences. “Ideal projects for this award could include new drug delivery systems, novel pharmaceutical products, innovative medical devices, new diagnostic tools, or technology to improve clinical trials”, he adds.
The award recipient will be chosen based on the novelty and power to advance medical research, and improve patient’s quality of life. The winner will be awarded a cash prize of $10,000. In addition to the cash prize, the award recipient will receive assistance by the PGBio team with the development of a business plan.
The submission deadline for this award is January 20th 2017. The Award recipient will be announced on April 14th 2017.
Point Guard Biosciences is devoted to finding, funding and developing innovative technologies in the areas of ophthalmic pharmaceuticals and medical devices. The staff of PGBio has extensive experiences developing ophthalmic products, raising venture capital and managing start-up companies. PGBio is a member of the Point Guard Partners (PGP) Family of companies. Other companies in the PGP family include Oculos Clinical Research, a full service ophthalmology-focused CRO and Oculos Consulting, which provides regulatory affairs and CMC consulting services to ophthalmic companies.
To learn more about all the companies in the PGP family, please visit our website: www.pointguardllc.com
Contact: Rosa Corrales, Ph.D